These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 31056316

  • 1. In vitro maturation rates in young premenarche patients.
    Karavani G, Schachter-Safrai N, Revel A, Mordechai-Daniel T, Bauman D, Imbar T.
    Fertil Steril; 2019 Aug; 112(2):315-322. PubMed ID: 31056316
    [Abstract] [Full Text] [Related]

  • 2. Prior exposure to chemotherapy does not reduce the in vitro maturation potential of oocytes obtained from ovarian cortex in cancer patients.
    Karavani G, Vedder K, Gutman-Ido E, Gruda Sussman R, Goldschmidt N, Mordechai-Daniel T, Ben-Meir A, Imbar T.
    Hum Reprod; 2023 Sep 05; 38(9):1705-1713. PubMed ID: 37414543
    [Abstract] [Full Text] [Related]

  • 3. In-vitro maturation of oocytes recovered during cryopreservation of pre-pubertal girls undergoing fertility preservation.
    Fouks Y, Hamilton E, Cohen Y, Hasson J, Kalma Y, Azem F.
    Reprod Biomed Online; 2020 Nov 05; 41(5):869-873. PubMed ID: 32843309
    [Abstract] [Full Text] [Related]

  • 4. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
    Abir R, Ben-Aharon I, Garor R, Yaniv I, Ash S, Stemmer SM, Ben-Haroush A, Freud E, Kravarusic D, Sapir O, Fisch B.
    Hum Reprod; 2016 Apr 05; 31(4):750-62. PubMed ID: 26848188
    [Abstract] [Full Text] [Related]

  • 5. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
    Creux H, Monnier P, Son WY, Tulandi T, Buckett W.
    Fertil Steril; 2017 Jan 05; 107(1):198-204. PubMed ID: 27810160
    [Abstract] [Full Text] [Related]

  • 6. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N.
    Hum Reprod; 2016 Mar 05; 31(3):623-9. PubMed ID: 26759139
    [Abstract] [Full Text] [Related]

  • 7. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
    Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, Grynberg M.
    Fertil Steril; 2019 Feb 05; 111(2):357-362. PubMed ID: 30527837
    [Abstract] [Full Text] [Related]

  • 8. Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?
    Lee JA, Barritt J, Moschini RM, Slifkin RE, Copperman AB.
    Fertil Steril; 2013 Apr 05; 99(5):1356-62. PubMed ID: 23266213
    [Abstract] [Full Text] [Related]

  • 9. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.
    Gayete-Lafuente S, Turan V, Oktay KH.
    J Assist Reprod Genet; 2023 Dec 05; 40(12):2777-2785. PubMed ID: 37715873
    [Abstract] [Full Text] [Related]

  • 10. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
    Hourvitz A, Yerushalmi GM, Maman E, Raanani H, Elizur S, Brengauz M, Orvieto R, Dor J, Meirow D.
    Reprod Biomed Online; 2015 Oct 05; 31(4):497-505. PubMed ID: 26278808
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of immature oocytes collected from ovarian tissue for cryopreservation in adult and prepubertal patients.
    Fasano G, Dechène J, Antonacci R, Biramane J, Vannin AS, Van Langendonckt A, Devreker F, Demeestere I.
    Reprod Biomed Online; 2017 Jun 05; 34(6):575-582. PubMed ID: 28365199
    [Abstract] [Full Text] [Related]

  • 12. At what age can human oocytes be obtained?
    Revel A, Revel-Vilk S, Aizenman E, Porat-Katz A, Safran A, Ben-Meir A, Weintraub M, Shapira M, Achache H, Laufer N.
    Fertil Steril; 2009 Aug 05; 92(2):458-63. PubMed ID: 18952208
    [Abstract] [Full Text] [Related]

  • 13. In-vitro maturation of germinal vesicle and metaphase I eggs prior to cryopreservation optimizes reproductive potential in patients undergoing fertility preservation.
    Lee JA, Sekhon L, Grunfeld L, Copperman AB.
    Curr Opin Obstet Gynecol; 2014 Jun 05; 26(3):168-73. PubMed ID: 24752002
    [Abstract] [Full Text] [Related]

  • 14. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation.
    Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC.
    Fertil Steril; 2008 Mar 05; 89(3):567-72. PubMed ID: 17543957
    [Abstract] [Full Text] [Related]

  • 15. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C, Simon C, Boubaya M, Benoit A, Sifer C, Sermondade N, Grynberg M.
    Hum Reprod; 2016 Jul 05; 31(7):1493-500. PubMed ID: 27165625
    [Abstract] [Full Text] [Related]

  • 16. Age-Dependent in vitro Maturation Efficacy of Human Oocytes - Is There an Optimal Age?
    Karavani G, Wasserzug-Pash P, Mordechai-Daniel T, Bauman D, Klutstein M, Imbar T.
    Front Cell Dev Biol; 2021 Jul 05; 9():667682. PubMed ID: 34222236
    [Abstract] [Full Text] [Related]

  • 17. Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center.
    Poirot C, Brugieres L, Yakouben K, Prades-Borio M, Marzouk F, de Lambert G, Pacquement H, Bernaudin F, Neven B, Paye-Jaouen A, Pondarre C, Dhedin N, Drouineaud V, Chalas C, Martelli H, Michon J, Minard V, Lezeau H, Doz F, Sarnacki S, Philippe-Chomette P, Dufour C, Laurence V, Baruchel A, Wolf JP, Boissel N, Valteau-Couanet D, Dalle JH.
    Acta Obstet Gynecol Scand; 2019 May 05; 98(5):630-637. PubMed ID: 30919447
    [Abstract] [Full Text] [Related]

  • 18. Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue.
    Yin H, Jiang H, Kristensen SG, Andersen CY.
    J Assist Reprod Genet; 2016 Jun 05; 33(6):741-6. PubMed ID: 26984232
    [Abstract] [Full Text] [Related]

  • 19. The study of the efficiency of in vitro maturation of ovarian tissue oocytes in pediatric patients.
    Ito K, Takae S, Nakamura K, Furuyama S, Nakajima M, Suzuki Y, Iwahata H, Sugishita Y, Horage Y, Suzuki N.
    J Assist Reprod Genet; 2023 Dec 05; 40(12):2787-2797. PubMed ID: 37779181
    [Abstract] [Full Text] [Related]

  • 20. Improving the maturation rate of human oocytes collected ex vivo during the cryopreservation of ovarian tissue.
    Nikiforov D, Junping C, Cadenas J, Shukla V, Blanshard R, Pors SE, Kristensen SG, Macklon KT, Colmorn L, Ernst E, Bay-Bjørn AM, Ghezelayagh Z, Wakimoto Y, Grøndahl ML, Hoffmann E, Andersen CY.
    J Assist Reprod Genet; 2020 Apr 05; 37(4):891-904. PubMed ID: 32096110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.